There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We evaluated capecitabine (an oral fluoropyrimidine) and oxaliplatin (a platinum compound)
as alternatives to infused fluorouracil and cisplatin, respectively, for untreated
advanced esophagogastric cancer.